Get The App!
Loading the player...
Therapy Interruption in Patients on Ruxolitinib
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
Srdan Verstovsek M.D., Ph.D., The University of Texas MD Anderson Cancer Center
Other Agents Nearing Approval for the Treatment of MPN's
Current Combination Strategies in the Clinical Setting
Best Treatment Approach in Patients with Low-Risk MF
Most Frequent Adverse Reactions in Patients with Ruxolitinib
Discussion on QOL Issues
Discussion on MPN Therapies
Typical Duration of Therapy with Ruxolitinib
Reasons People go off Ruxolitinib
Copyright 2020 by NSCI Group, Inc.
On The Go
About MedEd On The Go